Drug susceptibility in emerging fungal infections: tests with fluconazole, itraconazole, and amphotericin B
An. bras. dermatol
; 93(3): 462-464, May-June 2018. tab
Artigo
em Inglês
| LILACS
| ID: biblio-1038269
Biblioteca responsável:
BR1.1
ABSTRACT
Abstract The number of new cases of emerging fungal infections has increased considerably in recent years, mainly due to the large number of immunocompromised individuals. The objective of this study was to evaluate the susceptibility of emerging fungi to fluconazole, itraconazole and amphotericin B by disk diffusion method. In 2015, 82 emerging fungi were evaluated in IPB-LACEN/RS and 13 (15.8%) were resistant 10/52 were from superficial mycoses and 3/30 from systemic mycoses. The data from the study point to the need for permanent vigilance regarding the careful evaluation in the prescription and clinical and laboratory follow-up of patients affected by fungal infections.
Texto completo:
Disponível
Coleções:
Bases de dados internacionais
Base de dados:
LILACS
Assunto principal:
Farmacorresistência Fúngica
/
Fungos
/
Antifúngicos
Tipo de estudo:
Estudo de incidência
Limite:
Adulto
/
Idoso
/
Feminino
/
Humanos
/
Masculino
Idioma:
Inglês
Revista:
An. bras. dermatol
Assunto da revista:
Dermatologia
Ano de publicação:
2018
Tipo de documento:
Artigo
País de afiliação:
Brasil
Instituição/País de afiliação:
Secretaria de Saúde do Estado do Rio Grande do Sul/BR
/
Universidade Federal de Ciências da Saúde de Porto Alegre/BR